BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26093301)

  • 21. [Effect of Sapindus saponins on myocardial inflammation and left ventricular remodeling in spontaneously hypertensive rats].
    Chen M; Chen ZW; Long ZJ; Liu JL; Bian H; Wang YJ; Wang L
    Zhong Yao Cai; 2013 Feb; 36(2):249-55. PubMed ID: 23901653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
    Der Sarkissian S; Marchand EL; Duguay D; Hamet P; deBlois D
    Cardiovasc Res; 2003 Mar; 57(3):775-83. PubMed ID: 12618239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.
    Wu L; Wang R; De Champlain J; Wilson TW
    Am J Hypertens; 2004 Sep; 17(9):749-56. PubMed ID: 15363815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels.
    Lee CK; Han JS; Won KJ; Jung SH; Park HJ; Lee HM; Kim J; Park YS; Kim HJ; Park PJ; Park TK; Kim B
    Proteomics; 2009 Nov; 9(21):4851-8. PubMed ID: 19743417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats.
    Shinzato T; Ohya Y; Nakamoto M; Ishida A; Takishita S
    Hypertens Res; 2007 Sep; 30(9):863-73. PubMed ID: 18037780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of simvastatin on the left ventricular hypertrophy in spontaneously hypertensive rats and its relationship with the expression of protein kinase B].
    Zhao LY; Chen YQ; Zheng QS; Xue YS; Shang FJ; Li AG; Wang B
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1344-7. PubMed ID: 16029635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of angiotensin II on extracellular signal-regulated protein kinases signaling pathway in cultured vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats].
    Zhu JH; Liu Z; Huang ZY; Li S
    Sheng Li Xue Bao; 2005 Oct; 57(5):587-92. PubMed ID: 16220196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
    Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
    PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats.
    Majane OH; Vengethasamy L; du Toit EF; Makaula S; Woodiwiss AJ; Norton GR
    Hypertension; 2009 Dec; 54(6):1376-83. PubMed ID: 19841294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of platelet-derived growth factor receptor-mediated signal transduction in myocardial hypertrophy of spontaneously hypertensive rats.
    Liu J; Bai H; Xing DQ; Sun YP; Wu LL
    Sheng Li Xue Bao; 2002 Apr; 54(2):159-64. PubMed ID: 11973598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac benefits of exercise training in aging spontaneously hypertensive rats.
    Rossoni LV; Oliveira RA; Caffaro RR; Miana M; Sanz-Rosa D; Koike MK; Do Amaral SL; Michelini LC; Lahera V; Cachofeiro V
    J Hypertens; 2011 Dec; 29(12):2349-58. PubMed ID: 22045123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats.
    Li WX; Kong X; Zhang JX; Yang JR
    Food Funct; 2013 Feb; 4(3):453-60. PubMed ID: 23238059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of enalapril and hydralazine treatment and withdrawal upon cardiovascular hypertrophy in stroke-prone spontaneously hypertensive rats.
    King RA; Smith RM; Krishnan R; Cleary EG
    J Hypertens; 1992 Sep; 10(9):919-28. PubMed ID: 1328373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
    Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S; Ohkubo T; Tanaka Y; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy.
    Moens AL; Takimoto E; Tocchetti CG; Chakir K; Bedja D; Cormaci G; Ketner EA; Majmudar M; Gabrielson K; Halushka MK; Mitchell JB; Biswal S; Channon KM; Wolin MS; Alp NJ; Paolocci N; Champion HC; Kass DA
    Circulation; 2008 May; 117(20):2626-36. PubMed ID: 18474817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
    Zhai Y; Gao X; Wu Q; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2008 Jun; 587(1-3):196-203. PubMed ID: 18430418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.
    Thandapilly SJ; Wojciechowski P; Behbahani J; Louis XL; Yu L; Juric D; Kopilas MA; Anderson HD; Netticadan T
    Am J Hypertens; 2010 Feb; 23(2):192-6. PubMed ID: 19942861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.